- About bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Ranbaxy deal may help India’s entry into Japan
Financial Express | June 14, 2008
Ranbaxy deal may help India’s entry into Japan
New Delhi, Jun 13 — The Daiichi Sankyo-Ranbaxy Laboratories deal has come as a shot in the arm for India’s Comprehensive Economic Co-operation Agreement (CECA) negotiations with Japan. Indian pharma companies have been unable to break into Japan, the world’s second largest drug market, due to the country’s stringent sanitary and phytosanitary standards, technical barriers to trade (TBT) and environmental norms.
"The acquisition of Ranbaxy is arecognition of the quality of Indian drug and other pharma products bytheir Japanese counterparts. Before signing the CECA (Comprehensive Economic Cooperation Agreement), we will now aggressively push the case of our pharma sector as well as that of the chemicals, bio-tech and cosmetics sectors to ensure that Japan agrees to opening up their market for these products," a government official told FE.
Since the current Japanese standards on drugs and other pharmaceuticals products are higher than the accepted international standards, it amounts to a non-tariff barrier, the officialofficial added. India will ask Japan to bring their national standards to international levels and also ensure that there is a harmonization of SPS and TBT standards of both countries.
The government is, however, seeing the Ranbaxy deal as a bigger opportunity apart from getting a foothold in the $65 billion pharma market. In a bid to pave the way for the entry of Indian health industry into Japan, New Delhi would also pitch for relaxing the norms for movement of doctors, nurse and other health professionals from India to Japan.
Indian industry sees Japan’s drug approval procedures as stricter and time-consuming. Besides, it is also mandatory to get such products are tested in Japan itself as they do not accept products tested outside that country.
India would now demand that if the US FDA (Food and Drug Administration) has given approval to a drug, Japan must also allow it without any further testing. The government is also keeping a close watch on the deal’s impact on the Indian pharma market and if it would result in costlier drugs entering the country.
News from the movements
5-Mar-2015 Observatoire des multinationales
Politiques de libre échange et de dérégulation : « une immense incitation à industrialiser davantage l’agriculture européenne »Quel avenir pour l’agriculture ? Des fermes-usines rassemblant des milliers de vaches ou de porcelets ? Une participation massive des banques et fonds de pension dans le financement de l’agriculture ? Une dérégulation totale des marchés et une augmentation des importations ?
4-Mar-2015 CSNLes accords de libre-échange comme l’AÉCG ou le PTP rendront définitives les privatisations futures qui découleraient des mesures d’austérité.
3-Mar-2015 No al TTIP
Las/os europarlamentarias/os deben proteger a la ciudadanía ante la amenaza del tratado comercial entre UE-EEUUEl Parlamento Europeo está preparando un informe con su posicionamiento sobre las controvertidas negociaciones de la Asociación Transatlántica de Comercio e Inversión (TTIP, por sus siglas en inglés).
3-Mar-2015 NZ Not For SaleThe best chance to stop the TPPA is before ministers make their decisions. Join the nationwide day of action on 7 Mar 2015 in Aotearoa/NewZealand
UPDATE: The Transatlantic Trade and Investment Partnership (TTIP): A charter for deregulation, an attack on jobs, an end to democracyRosa Luxemburg Stiftung have today released an updated version of their publication on TTIP by John Hilary.
26-Feb-2015 El FaradioDesde Izquierda Unida este viernes se ha organizado un acto público en el Colegio Público Cisneros sobre el Tratado de Libre Comercio e Inversiones entre EEUU y la Unión Europea (TTIP).
26-Feb-2015 IGJIndonesia for Global Justice together with Indonesian civil society networks met with the Director of Bilateral Cooperation of Investment Coordinating Board, Fritz Horas Silalahi, in Jakarta to discuss the review of Indonesia Bilateral Investment Treaties (BITS).
25-Feb-2015 Financial ExpressProf Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with the US and its investors is dangerous to hundreds of millions of people worldwide whose lives depend on Indian generics
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Join us.